NCT00090168已完成3 期
A Multicenter Study to Assess the Cholesterol Lowering Level of Switching to an Investigational Drug Compared to Doubling the Dose of an Investigational Drug in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 435
- 主要终点
- LDL-C lowering
研究概览
简要总结
A 6-week treatment study to compare the reduction in cholesterol of two drugs MK0653A+Simvastatin for high cholesterol, in patients with hypercholesterolemia and atherosclerotic or coronary vascular disease.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •- Men and women greater than or equal to 18 years of age with elevated cholesterol levels and coronary heart disease (CHD), or atherosclerotic vascular disease may be eligible to participate in this study.
排除标准
- 未提供
结局指标
主要结局
LDL-C lowering
次要结局
- Total cholesterol (TC) lowering
研究者
相似试验
已完成
3 期
Eze/Simva Switch Study in Diabetics (0653A-807)Diabetes Mellitus, Type 2NCT00541697Organon and Co648
已完成
3 期
A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)Type 2 Diabetes MellitusHypercholesterolemiaNCT00110435Organon and Co1,229
已完成
3 期
Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)HypercholesterolemiaNCT00092586Organon and Co2,904
已完成
3 期
Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)HypercholesterolemiaNCT00090298Organon and Co2,815
已完成
4 期
Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With HypercholesterolemiaHypercholesterolemiaNCT00141141Pfizer's Upjohn has merged with Mylan to form Viatris Inc.383